Absci (ABSI) Gains from Investment Securities (2020 - 2025)
Absci's (ABSI) quarterly Gains from Investment Securities came in at $2000.0 in Q4 2025, down 99.65% year-on-year from $571000.0 in Q4 2024, and down 97.4% quarter-over-quarter from $77000.0 in Q3 2025.
Absci (ABSI) Gains from Investment Securities (2020 - 2025) Analysis & Trends
Absci has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $2000.0 for Q4 2025.
- Gains from Investment Securities for Q4 2025 came in at $2000.0, down 99.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $32000.0 (down 95.39% YoY), and the FY2025 annual result was $79000.0, down 87.71% from the prior year.
- Gains from Investment Securities came in at $2000.0 for Q4 2025 at Absci, down from $77000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.5 million in Q4 2021 to a low of -$1.3 million in Q3 2022.
- The 5-year median for Gains from Investment Securities is $47000.0 (2025), against an average of $270842.1.
- Across the five-year window, Gains from Investment Securities plunged 1630.14% in 2022 and soared 2025.0% in 2025, its largest moves.
- Absci's Gains from Investment Securities stood at $2.5 million in 2021, then sank by 99.92% to $2000.0 in 2022, then slumped by 4000.0% to -$78000.0 in 2023, then surged by 832.05% to $571000.0 in 2024, then sank by 99.65% to $2000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $2000.0 (Q4 2025), $77000.0 (Q3 2025), and -$47000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Absci | 1.13 Bn | 1.01 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Dec 31, 2025 | 2,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Sep 30, 2025 | 77,000.00 |
| Jun 30, 2025 | -47,000.00 |
| Jun 30, 2025 | -47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Dec 31, 2024 | 571,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 80,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Sep 30, 2023 | -78,000.00 |
| Sep 30, 2023 | -78,000.00 |
| Jun 30, 2023 | -593,000.00 |
| Jun 30, 2023 | -593,000.00 |